N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential?

@article{Mendoza2009NDesmethylclozapineIT,
  title={N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential?},
  author={M. Mendoza and J. Lindenmayer},
  journal={Clinical Neuropharmacology},
  year={2009},
  volume={32},
  pages={154-157}
}
  • M. Mendoza, J. Lindenmayer
  • Published 2009
  • Psychology, Medicine
  • Clinical Neuropharmacology
    • Objective:N-Desmethylclozapine (NDMC), one of clozapine's major metabolites, has become a recent focus of study for both its antipsychotic and metabolic effects. The aim of this review is to examine NDMC's biological activity in the context of the pathophysiology of schizophrenia and to critically evaluate the few recent preclinical and clinical studies of NDMC's potential antipsychotic effects to predict its therapeutic potential. Results:We review the complex interaction between clozapine and… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    32 Citations
    Background Citations
    13
    Results Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    32 Citations
    Citation Type

    Citation Type

    Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
    • 38
    The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
    • 13
    Effects of clozapine and N-desmethylclozapine on synaptic transmission at hippocampal inhibitory and excitatory synapses
    • 9
    Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients
    • 12
    The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia
    Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia
    Electrophysiological evidence showing muscarinic agonist–antagonist activities of N-desmethylclozapine using hippocampal excitatory and inhibitory neurons
    Muscarinic mechanisms in psychotic disorders.
    • 16
    Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study
    • 14
    Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations
    • 10

    References

    SHOWING 1-10 OF 25 REFERENCES
    Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies
    • 41
    • PDF
    N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors
    • 116
    • PDF
    The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine
    • 189
    Pharmacology of N-desmethylclozapine.
    • 76
    Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
    • 115
    • Highly Influential
    The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
    • 137
    N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity
    • C. Sur, P. Mallorga, +7 authors P. J. Conn
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 2003
    • 243
    • PDF
    N-Desmethylclozapine, a Major Clozapine Metabolite, Acts as a Selective and Efficacious δ-Opioid Agonist at Recombinant and Native Receptors
    • 22
    • PDF
    Pharmacokinetics and Pharmacodynamics of Clozapine
    • 190
    • Highly Influential
    N‐desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis
    • 78